Table 1.
Drug | Structure | Action | Reference |
---|---|---|---|
Anakinra | Recombinant IL-1 receptor antagonist, block cytokine storm. | [184] | |
Azithromycin | Antiviral, anti-inflammatory. | [241,248] | |
Baricitinib | Anti-inflammatory Janus Kinase (JAK) inhibitor, block cytokine storm. | [187] | |
Chloroquine | Increases endosomal pH and alters glycosylation of ACE-2, interfering with virus/receptor interaction. | [249] | |
Dexamethasone | Steroid, anti-inflammatory, suppression of cytokine storm | [170] | |
Favipiravir | Antiviral, RNA-dependent RNA polymerase inhibitor. | [156] | |
Heparin | It can reverse the hypercoagulation in severe cases of COVID-19. | [173] | |
Hydroxychloroquine | Increases endosomal pH and alters glycosylation of ACE-2, interfering with virus/receptor interaction. | [241] | |
Interferons (IFN) | – | Inhibits viral RNA transcription, protein translation and post translational modification. | [191] [198], |
Ivermectin | Antiviral, inhibits viral replication and assembly of new virions. | [136] [137], | |
Lopinavir | Inhibits 3CL protease activity, Blockage of protein processing. | [144] | |
Losartan | Angiotensin receptor blocker, interferes with renin-angiotensin system and blood vessels constriction/vasodilation. | [210] | |
Methylprednisolone | Anti-inflammatory, suppress cytokine- related lung injury, block cytokine storm | [168] | |
Nitazoxanide | Antiviral, interferes with 3CL protease activity | [147] | |
Remdesivir | Inhibits RdRp polymerase inhibiting RNA synthesis. | [120,152] | |
Ritonavir | Inhibits 3CL protease activity, blockage of protein processing. | [144] | |
Tocilizumab | – | Interleukin-6 inhibitor, Humanized mAb targeting IL-6, Immunosuppressive, blockage of cytokine storm. | [189,190] |
Umifenovir (Arbidol) | Interacts with spike glycoprotein and impedes its trimerization, which is key for host cell adhesion and hijacking. | [250] | |
Vitamin C | Boosts immunity by stimulating IFN production, stimulating lymphocyte proliferation and enhancing neutrophil phagocytic capability. | [231] | |
Vitamin D | immunomodulatory property. | [234] |
Structures from National Center for Biotechnology Information. PubChem Database. https://pubchem.ncbi.nlm.nih.gov (accessed on June 16, 2020).